Ultra-high field 7T MRI: A new tool for studying Alzheimers Disease

Journal of Alzheimer's Disease

Volumn 26, Issue SUPPL. 3, 2011, Pages 91-95

  Kerchner, Geoffrey A ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

7 Tesla (7T); Alzheimers disease; beta amyloid; biomarker; CA1; hippocampus; magnetic resonance imaging (MRI)

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; DIAGNOSTIC VALUE; HIPPOCAMPUS; HUMAN; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SENILE PLAQUE;

EID: 80055042286     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2011-0023     Document Type: Article

References (40)

1. Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, Bergstrom M, Savitcheva I, Huang GF, Estrada S, Ausen B, Debnath ML, Barletta J, Price JC, Sandell J, Lopresti BJ, Wall A, Koivisto P, Antoni G, Mathis CA, Langstrom B (2004) Imaging brain amyloid in Alzheimers disease with Pittsburgh Compound-B. Ann Neurol 55, 306-319. (Pubitemid 38269583)
2. Wengenack T, Jack C, Garwood M, Poduslo J (2008) MR Microimaging of amyloid plaques in Alzheimers disease transgenic mice. European Journal of Nuclear Medicine and Molecular Imaging 35, 82-88.
3. Jack CR, Marjanska M, Wengenack TM, Reyes DA, Curran GL, Lin J, Preboske GM, Poduslo JF, Garwood M (2007) Magnetic resonance imaging of Alzheimers pathology in the brains of living transgenic mice: a new tool in Alzheimers disease research. The Neuroscientist 13, 38-48. (Pubitemid 46052752)
4. Benveniste H, Einstein G, Kim KR, Hulette C, Johnson GA (1999) Detection of neuritic plaques in Alzheimers disease by magnetic resonance microscopy. Proc Natl Acad Sci U S A 96, 14079-14084.
5. Meadowcroft MD, Connor JR, Smith MB, Yang QX (2009) MRI and histological analysis of beta-amyloid plaques in both human Alzheimers disease and APP/PS1 transgenic mice. J Magn Reson Imaging 29, 997-1007.
6. Jack CR, Garwood M, Wengenack TM, Borowski B, Curran GL, Lin J, Adriany G, Gröhn OHJ, Grimm R, Poduslo JF (2004) In vivo visualization of Alzheimers amyloid plaques by magnetic resonance imaging in transgenic mice without a contrast agent. Magn Reson Med 52, 1263-1271. (Pubitemid 39612814)
7. Zhang J, Yarowsky P, Gordon MN, Di Carlo G, Munireddy S, van Zijl PC, Mori S (2004) Detection of amyloid plaques in mouse models of Alzheimers disease by magnetic resonance imaging. Magn Reson Med 51, 452-457. (Pubitemid 38298656)
8. Lee S-P, FalangolaMF, Nixon RA, DuffK, Helpern JA(2004) Visualization of-amyloid plaques in a transgenic mouse model of Alzheimers disease using MR microscopy without contrast reagents. Magn Reson Med 52, 538-544. (Pubitemid 39108965)
9. Faber C, Zahneisen B, Tippmann F, Schroeder A, Fahrenholz F (2007) Gradient-echo and CRAZED imaging for minute detection of Alzheimer plaques in an APPV717IADAM10-dn mouse model. Magn Reson Med 57, 696-703. (Pubitemid 46731795)
10. Poduslo JF, Wengenack TM, Curran GL, Wisniewski T, Sigurdsson EM, Macura SI, Borowski BJ, Jack CR (2002) Molecular targeting of Alzheimers amyloid plaques for contrast-enhanced magnetic resonance imaging. Neurobiol Dis 11, 315-329. (Pubitemid 36135695)
11. Chamberlain R, Reyes D, Curran GL, Marjanska M, Wengenack TM, Poduslo JF, Garwood M, Jack CR (2009) Comparison of amyloid plaque contrast generated by T2-weighted, T2*-weighted, and susceptibility-weighted imaging methods in transgenic mouse models of Alzheimers disease. Magn Reson Med 61, 1158-1164.
12. Wadghiri YZ, Sigurdsson EM, Sadowski M, Elliott JI, Li Y, Scholtzova H, Tang CY, Aguinaldo G, Pappolla M, Duff K, Wisniewski T, Turnbull DH (2003) Detection of Alzheimers amyloid in transgenic mice using magnetic resonance microimaging. Magn Reson Med 50, 293-302. (Pubitemid 36950848)
13. Higuchi M, Iwata N, Matsuba Y, Sato K, Sasamoto K, Saido TC (2005) 19F and 1H MRI detection of amyloid beta plaques in vivo. Nat Neurosci 8, 527-533. (Pubitemid 41007572)
14. Teipel SJ, Kaza E, Hadlich S, Bauer A, Brüning T, Plath A-S, Krohn M, Scheffler K,Walker LC, Lotze M, Pahnke J (2011) Automated detection of amyloid related cortical and subcortical signal changes in a transgenic model of Alzheimers disease using high-field MRI. Journal of Alzheimers Disease 23, 221-237.
15. Borthakur A, Gur T, Wheaton AJ, Corbo M, Trojanowski JQ, Lee VMY, Reddy R (2006) In vivo measurement of plaque burden in a mouse model of Alzheimers disease. J Magn Reson Imaging 24, 1011-1017. (Pubitemid 44658237)
16. Helpern JA, Lee SP, Falangola MF, Dyakin VV, Bogart A, Ardekani B, Duff K, Branch C, Wisniewski T, de Leon MJ, Wolf O, OShea J, Nixon RA (2004) MRI assessment of neuropathology in a transgenic mouse model of Alzheimers disease. Magn Reson Med 51, 794-798. (Pubitemid 38420457)
17. Braakman N, Matysik J, van Duinen SG, Verbeek F, Schliebs R, de Groot HJM, Alia A (2006) Longitudinal assessment of Alzheimers-amyloid plaque development in transgenic mice monitored by in vivo magnetic resonance microimaging. J Magn Reson Imaging 24, 530-536. (Pubitemid 44320553)
18. Jack CR Jr,Wengenack TM, Reyes DA, Garwood M, Curran GL, Borowski BJ, Lin J, Preboske GM, Holasek SS, Adriany G, Poduslo JF (2005) In vivo magnetic resonance microimaging of individual amyloid plaques in Alzheimers transgenic mice. J Neurosci 25, 10041-10048. (Pubitemid 41528043)
19. Vanhoutte G, Dewachter I, Borghgraef P, Van Leuven F, Van der Linden A (2005) Noninvasive in vivo MRI detection of neuritic plaques associated with iron in APP V717I transgenic mice, a model for Alzheimers disease. Magn Reson Med 53, 607-613. (Pubitemid 40332281)
20. Nakada T, Matsuzawa H, Igarashi H, Kwee YFIL (2008) In vivo visualization of senile-plaque-like pathology in Alzheimers disease patients by MR microscopy on a 7T system. J Neuroimaging 18, 125-129. (Pubitemid 351463961)
21. Dhenain M, Privat N, Duyckaerts C, Jacobs RE (2002) Senile plaques do not induce susceptibility effects in T2-weighted MR microscopic images. NMR Biomed 15, 197-203. (Pubitemid 34520660)
22. Rabinovici GD, Jagust WJ (2009) Amyloid imaging in aging and dementia: Testing the amyloid hypothesis in vivo. Behavioural Neurology 21, 117-128.
23. Kerchner GA, Boxer AL (2010) Bapineuzumab. Expert Opin Biol Ther 10, 1121-1130.
24. Holmes C, Boche D,Wilkinson D, Yadegarfar G, Hopkins V, Bayer A, Jones RW, Bullock R, Love S, Neal JW, Zotova E, Nicoll JAR (2008) Long-term effects of A-42 immunisation in Alzheimers disease: follow-up of a randomised, placebocontrolled phase I trial. The Lancet 372, 216-223. (Pubitemid 351978111)
25. Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K (2006) Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol (Berl) 112, 389-404. (Pubitemid 44469160)
26. Frisoni GB, Fox NC, Jack CR, Scheltens P, Thompson PM (2010) The clinical use of structural MRI in Alzheimer disease. Nat Rev Neurol 6, 67-77.
27. Braak E, Braak H (1997) Alzheimers disease: transiently developing dendritic changes in pyramidal cells of sector CA1 of the Ammons horn. Acta Neuropathol 93, 323-325. (Pubitemid 27153697)
28. Thal DR, Holzer M, Rub U,Waldmann G, Gunzel S, Zedlick D, Schober R (2000) Alzheimer-related tau-pathology in the perforant path target zone and in the hippocampal stratum oriens and radiatum correlates with onset and degree of dementia. Exp Neurol 163, 98-110. (Pubitemid 30314364)
29. Lace G, SavvaGM,Forster G, de SilvaR, Brayne C, Matthews FE, Barclay JJ, Dakin L, Ince PG, Wharton SB (2009) Hippocampal tau pathology is related to neuroanatomical connections: an ageing population-based study. Brain 132, 1324-1334.
30. Mizutani T, Kasahara M (1997) Hippocampal atrophy secondary to entorhinal cortical degeneration in Alzheimer-type dementia. Neurosci Lett 222, 119-122. (Pubitemid 27077324)
31. Scheff SW, Price DA, Schmitt FA, DeKosky ST, Mufson EJ (2007) Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment. Neurology 68, 1501-1508. (Pubitemid 46685921)
32. Kerchner GA, NicollRA(2008) Silent synapses and the emergence of a postsynaptic mechanism for LTP. Nat Rev Neurosci 9, 813-825.
33. Kerchner GA, Hess CP, Hammond-Rosenbluth KE, Xu D, Rabinovici GD,KelleyDAC,Vigneron DB, Nelson SJ, Miller BL (2010) Hippocampal CA1 apical neuropil atrophy in mild Alzheimer disease visualized with 7-T MRI. Neurology 75, 1381-1387.
34. Thomas BP, Welch EB, Niederhauser BD, Whetsel WO, Anderson AW, Gore JC, Avison MJ, Creasy JL (2008) Highresolution 7T MRI of the human hippocampus in vivo.JMagn Reson Imaging 28, 1266-1272.
35. Theysohn JM, Kraff O, Maderwald S, Schlamann MU, de Greiff A, Forsting M, Ladd SC, Ladd ME, Gizewski ER (2009) The human hippocampus at 7 T-in vivo MRI. Hippocampus 19, 1-7.
36. Koopmans PJ, Barth M, Orzada S, Norris DG (2011) Multi-echo fMRI of the cortical laminae in humans at 7T. Neuroimage 56, 1276-1285.
37. Versluis MJ, Peeters JM, van Rooden S, van der Grond J, van Buchem MA, Webb AG, van Osch MJP (2010) Origin and reduction of motion and f0 artifacts in high resolution T2*-weighted magnetic resonance imaging: Application in Alzheimers disease patients. Neuroimage 51, 1082-1088.
38. von Morze C, Kelley DAC, Shepherd TM, Banerjee S, Xu D, Hess CP (2010) Reduced field-of-view diffusion-weighted imaging of the brain at 7 T. Magn Reson Imaging 28, 1541-1545.
39. Theysohn JM, Kraff O, Maderwald S, Barth M, Ladd SC, Forsting M, Ladd ME, Gizewski ER (2011) 7 tesla MRI of microbleeds and white matter lesions as seen in vascular dementia. J Magn Reson Imaging 33, 782-791.
40. Eapen M, Zald DH, Gatenby JC, Ding Z, Gore JC (2011) Using high-resolution MR imaging at 7T to evaluate the anatomy of the midbrain dopaminergic system. American Journal of Neuroradiology 32, 688-694.